Even Less Incentive For Pharma To Innovate Threatens Global Health & Our Economy The structure of the modern healthcare ecosystem has already made a mess of the incentives facing pharmaceutical companies. Now without intellectual property protections for new vaccines, manufacturers have even less incentive to innovate.